With more than four million cases and just under 300,000 deaths to date, the pressure created by the coronavirus pandemic is enormous.
But Irish companies are coming out in force to try to solve the problem, tackling elements of everything from drug trials to innovative tech solutions to manage patient care.
The organisations stepping up to the challenge include everyone from universities and start-ups to Irish-founded companies operating globally.
Open Orphan (LON:ORPH) was founded in 2017, with the goal of rapidly building Europe’s leading pharma services company by a management team with extensive industry and financial expertise. The company comprises of two commercial specialist CRO services businesses (Venn Life Sciences and hVIVO) and is also developing a genomics data platform business (Genomic Health Data).